- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 11, 2025 | 2.52M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 21.79K sh |
| Capex | FY 2024 · Dec 31, 2023 | $530K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$14.12M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $3.34M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $2.91M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.59M |
| Current Assets | FY 2024 · Dec 31, 2023 | $5.53M |
| Total Assets | FY 2024 · Dec 31, 2023 | $15.37M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$624.47 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$443.47 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $4.22M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $8.71M |
| Net Income | FY 2024 · Dec 31, 2023 | −$8.26M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$13.36M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $1.84M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $784K |
| Revenue | FY 2024 · Dec 31, 2023 | $2.63M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $5.7M |